Methods for treating disruptive behavior disorders

Details for Australian Patent Application No. 2007329779 (hide)

Owner Janssen Pharmaceuticals, N.V.

Inventors Haas, Magali

Agent Shelston IP

Pub. Number AU-A-2007329779

PCT Pub. Number WO2008/070277

Priority 60/863,137 27.10.06 US

Filing date 11 October 2007

Wipo publication date 12 June 2008

International Classifications

A61K 31/27 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

28 May 2009 PCT application entered the National Phase

  PCT publication WO2008/070277 Priority application(s): WO2008/070277

22 September 2011 Assignment before Grant

  Janssen Pharmaceuticals, N.V. The application has been assigned to SK Biopharmaceuticals Co., Ltd.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007329788-Method and apparatus for geomodel uplayering

2007329776-Alteration of tobacco alkaloid content through modification of specific cytochrome P450 genes